Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers von KISER, Jennifer J, BUMPASS, J. Brock, MEDITZ, Amie L, ANDERSON, Peter L, BUSHMAN, Lane, RAY, Michelle, PREDHOMME, Julie A, ROWER, Joseph, MAWHINNEY, Sam, BRUNDAGE, Richard

Volltext

Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists von Bumpass, J. Brock, McDaneld, Patrick M., DePestel, Daryl D., Lamp, Kenneth C., Chung, Thomas J., McKinnon, Peggy S., Crompton, Monica G., Hermsen, Elizabeth D.

Volltext

6 PROJECTED PREVALENCE OF CIRRHOSIS AND OVERT HEPATIC ENCEPHALOPATHY IN THE UNITED STATES, 2021–2030 von Wong, Robert, Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Maitland, Jessica, Bellefleur, Remi, Guérin, Annie, Joseph, George, Samson, Aaron, Olujohungbe, Olamide, Bumpass, Brock, Dashputre, Ankur A.

Volltext

42174 Treatment patterns and inadequate symptom control among commercially insured patients with moderate-to-severe acne vulgaris in the US: A retrospective cohort study von Harper, Julie, Dashputre, Ankur A., Brunetti, Vanessa, Serra, Elizabeth, Borroto, Danellys, Gagnon-Sanschagrin, Patrick, Lin, Tina, Bumpass, Brock, Guerin, Annie, Joseph, George

Volltext

Tu1524 PERCEPTION OF MODERATE TO HIGH RISK FACTORS FOR DEVELOPING PRIMARY OVERT HEPATIC ENCEPHALOPATHY ACROSS PHYSICIAN SPECIALTIES IN THE UNITED STATES von Jesudian, Arun, Heimanson, Zeev, Gagnon-Sanschagrin, Patrick, Hazra, Nisha C., Bellefleur, Remi, Guérin, Annie, Dashputre, Ankur A., Bumpass, Brock, Borroto, Danellys, Joseph, George

Volltext

729 IMPACT OF RIFAXIMIN USE DURING THE 30-DAY POST-DISCHARGE PERIOD FOLLOWING AN OVERT HEPATIC ENCEPHALOPATHY HOSPITALIZATION ON HEALTHCARE UTILIZATION AND COSTS von Jesudian, Arun, Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Bungay, Rebecca, Chen, Jingyi, Guérin, Annie, Dashputre, Ankur A., Bumpass, Brock, Borroto, Danellys, Joseph, George

Volltext

Su1546 REAL-WORLD TRENDS IN THE PREVALENCE OF CIRRHOSIS AND RATES OF HEPATIC ENCEPHALOPATHY AMONG ADULTS IN THE UNITED STATES FROM 2006-2020 von Wong, Robert, Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Maitland, Jessica, Qu, Wendi, Guérin, Annie, Dashputre, Ankur A., Bumpass, Brock, Olujohungbe, Olamide, Borroto, Danellys, Joseph, George

Volltext

Tu1522 LONG TERM CARE SERVICES USE AMONG MEDICARE PATIENTS TREATED WITH RIFAXIMIN FOR OVERT HEPATIC ENCEPHALOPATHY von Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Allen, Christopher, Maitland, Jessica, Davidson, Mikhail, Zhang, Adina, Chen, Jingyi, Guérin, Annie, Dashputre, Ankur A., Bumpass, Brock, Olujohungbe, Olamide, Borroto, Danellys, Joseph, George

Volltext

Impact of rifaximin use post-discharge of an overt hepatic encephalopathy (OHE) hospitalization on the annual rates of OHE-related inpatient stays von Jesudian, Arun, Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Bungay, Rebecca, Chen, Jingyi, Guérin, Annie, Dashputre, Ankur, Bumpass, Brock, Borroto, Danellys, Joseph, George

Volltext

SAT-339 - Impact of rifaximin use post-discharge of an overt hepatic encephalopathy (OHE) hospitalization on the annual rates of OHE-related inpatient stays von Jesudian, Arun, Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Bungay, Rebecca, Chen, Jingyi, Guérin, Annie, Dashputre, Ankur, Bumpass, Brock, Borroto, Danellys, Joseph, George

Volltext

25406 Comparison of biologic initiation and health care costs among patients with psoriasis receiving fixed-dose combination halobetasol-propionate 0.01%/tazarotene 0.045% (HP/TAZ)... von Kircik, Leon, Joseph, George, Gagnon-Sanschagrin, Patrick, Bumpass, Brock, Serra, Elizabeth, Lin, Tina, Jacobson, Abby, Guérin, Annie, Glick, Brad P.

Volltext

Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea von Lacy, Brian E., Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Bungay, Rebecca, Bellefleur, Remi, Guérin, Annie, Bumpass, Brock, Borroto, Danellys, Joseph, George, Dashputre, Ankur A.

Volltext

Impact of rifaximin use following an initial overt hepatic encephalopathy hospitalization on rehospitalization and costs von Jesudian, Arun B., Gagnon-Sanschagrin, Patrick, Heimanson, Zeev, Bungay, Rebecca, Chen, Jingyi, Guérin, Annie, Bumpass, Brock, Borroto, Danellys, Joseph, George, Dashputre, Ankur A.

Volltext